Acorda Therapeutics, Inc. is an American biotechnology company based in New York and founded in 1995 by Ron Cohen that develops therapies that improve neurological function in people and manufactures and markets the drugs Inbrija and Ampyra.
Acorda Therapeutics, Inc. is an American biotechnology company based in New York and founded in 1995 by Ron Cohen that develops therapies that improve neurological function in people and manufactures and markets the drugs Inbrija and Ampyra.